| Poly (ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease TI Kam, X Mao, H Park, SC Chou, SS Karuppagounder, GE Umanah, ... Science 362 (6414), eaat8407, 2018 | 392 | 2018 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 372 | 2018 |
| Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ... Nature genetics 53 (3), 294-303, 2021 | 212 | 2021 |
| GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease IF Mata, JB Leverenz, D Weintraub, JQ Trojanowski, A Chen‐Plotkin, ... Movement Disorders 31 (1), 95-102, 2016 | 209 | 2016 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 178 | 2020 |
| Finding useful biomarkers for Parkinson’s disease AS Chen-Plotkin, R Albin, R Alcalay, D Babcock, V Bajaj, D Bowman, ... Science translational medicine 10 (454), eaam6003, 2018 | 108 | 2018 |
| Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross … T Simuni, L Uribe, HR Cho, C Caspell-Garcia, CS Coffey, A Siderowf, ... The Lancet Neurology 19 (1), 71-80, 2020 | 105 | 2020 |
| The NINDS Parkinson's disease biomarkers program LS Rosenthal, D Drake, RN Alcalay, D Babcock, FDB Bowman, ... Movement Disorders 31 (6), 915-923, 2016 | 95 | 2016 |
| Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, ... JAMA neurology 78 (3), 312-320, 2021 | 94 | 2021 |
| Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study E Jabbari, S Koga, RR Valentino, RH Reynolds, R Ferrari, MMX Tan, ... The Lancet Neurology 20 (2), 107-116, 2021 | 83 | 2021 |
| Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial B Bluett, DM Togasaki, D Mihaila, M Evatt, M Rezak, S Jain, ... Jama 326 (10), 926-939, 2021 | 82 | 2021 |
| Cognitive profile of LRRK2‐related Parkinson's disease S Srivatsal, B Cholerton, JB Leverenz, ZK Wszolek, RJ Uitti, DW Dickson, ... Movement Disorders 30 (5), 728-733, 2015 | 77 | 2015 |
| Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies JT Geiger, J Ding, B Crain, O Pletnikova, C Letson, TM Dawson, ... Neurobiology of disease 94, 55-62, 2016 | 69 | 2016 |
| The benefits of exercise in Parkinson disease LS Rosenthal, ER Dorsey JAMA neurology 70 (2), 156-157, 2013 | 55 | 2013 |
| Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease D Weintraub, C Caspell‐Garcia, T Simuni, HR Cho, CS Coffey, ... Annals of clinical and translational neurology 7 (4), 449-461, 2020 | 50 | 2020 |
| Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease LM Chahine, C Dos Santos, M Fullard, C Scordia, D Weintraub, G Erus, ... European journal of neurology 26 (2), 246-e18, 2019 | 49 | 2019 |
| Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program K Gwinn, KK David, C Swanson-Fischer, R Albin, CS Hillaire-Clarke, ... Biomarkers in medicine 11 (6), 451-473, 2017 | 47 | 2017 |
| Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease JT Hinkle, K Perepezko, KA Mills, Z Mari, A Butala, TM Dawson, ... Parkinsonism & related disorders 55, 8-14, 2018 | 46 | 2018 |
| Stress and mindfulness in Parkinson’s disease–a survey in 5000 patients A van der Heide, AEM Speckens, MJ Meinders, LS Rosenthal, BR Bloem, ... npj Parkinson's Disease 7 (1), 7, 2021 | 45 | 2021 |
| Gait variability in spinocerebellar ataxia assessed using wearable inertial sensors VV Shah, R Rodriguez‐Labrada, FB Horak, J McNames, H Casey, ... Movement Disorders 36 (12), 2922-2931, 2021 | 41 | 2021 |
